Skip to Main Content

Michael Schilsky, MD

Professor of Medicine; Medical Director, Adult Liver Transplant at Yale-New Haven Transplantation Center

Research Summary

I participate as an investigator in the NIH sponsored Acute Liver Failure Study Group. I am an investigator in clinical trials for patients with Wilson disease and advanced liver disease.

Extensive Research Description

I participate as an investigator in the NIH sponsored Acute Liver Failure Study Group where we have been focusing on patients with acute liver failure to advance our understanding of this uncommon disorder.

I am an investigator in clinical trials for patients with Wilson disease, including the testing of once daily use of trientine for maintenance therapy, and the novel agent WTX 101 (choline-tetrathiomolybdate).


Coauthors

Research Interests

Copper; Liver Transplantation; Liver Failure, Acute

Selected Publications

Clinical Trials

ConditionsStudy Title
Diseases of the Nervous SystemTrientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
Genetics - AdultEfficacy and Safety of WTX101 Administered for 48 Weeks Versus Standard of Care in Wilson Disease Subjects
Diseases of the Digestive System - Liver; Diseases of the Eye; Diseases of the Nervous SystemWilson Disease Registry
Hepatitis; HIV/AIDS; Immune System; Infectious DiseasesScreening In Anticipation of Future Research